Որոնման արդյունքները - Lill‐Tove Busund
- Ցուցադրվում են 1 - 20 արդյունքները 36
- Գնացեք Հաջորդ էջ
-
1
-
2
Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study Line Moi, Tonje Braaten, Khalid Al‐Shibli, Eiliv Lund, Lill‐Tove Busund
Հրապարակվել է 2019Artigo -
3
-
4
Combination of low vascular endothelial growth factor A (VEGF‐A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and independent favorable prognostic factor... Tom Dønnem, Khalid Al‐Shibli, Sigve Andersen, Samer Al‐Saad, Lill‐Tove Busund, Roy M. Bremnes
Հրապարակվել է 2010Artigo -
5
-
6
-
7
Overexpression of the HIF Hydroxylases PHD1, PHD2, PHD3 and FIH Are Individually and Collectively Unfavorable Prognosticators for NSCLC Survival Sigve Andersen, Tom Dønnem, Helge Stenvold, Samer Al‐Saad, Khalid A. Alshibli, Lill‐Tove Busund, Roy M. Bremnes
Հրապարակվել է 2011Artigo -
8
High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence Yngve Nordby, Elin Richardsen, Mehrdad Rakaee, Nora Ness, Tom Dønnem, Hiten Patel, Lill‐Tove Busund, Roy M. Bremnes, Sigve Andersen
Հրապարակվել է 2017Artigo -
9
CD4/CD8 co-expression shows independent prognostic impact in resected non-small cell lung cancer patients treated with adjuvant radiotherapy Sigurd M. Hald, Roy M. Bremnes, Khalid Al‐Shibli, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Lill‐Tove Busund, Tom Dønnem
Հրապարակվել է 2013Artigo -
10
-
11
-
12
The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer Roy M. Bremnes, Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Sigve Andersen, Rafael Sirera, Carlos Camps, Inigo Marinez, Lill‐Tove Busund
Հրապարակվել է 2010Revisão -
13
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung Cancer Roy M. Bremnes, Khalid Al‐Shibli, Tom Dønnem, Rafael Sirera, Samer Al‐Saad, Sigve Andersen, Helge Stenvold, Carlos Camps, Lill‐Tove Busund
Հրապարակվել է 2010Revisão -
14
Inverse Prognostic Impact of Angiogenic Marker Expression in Tumor Cells versus Stromal Cells in Non–Small Cell Lung Cancer Tom Dønnem, Samer Al‐Saad, Khalid Al‐Shibli, Marit Pedersen Delghandi, Magnus Persson, Marit N. Nilsen, Lill‐Tove Busund, Roy M. Bremnes
Հրապարակվել է 2007Artigo -
15
Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer Thomas K. Kilvaer, Mehrdad Rakaee, Turid Hellevik, Arne Östman, Carina Strell, Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Iñigo Martínez-Zubiaurre
Հրապարակվել է 2018Artigo -
16
Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth Turid Hellevik, Ingvild Pettersen, Vivian Berg, Jack‐Ansgar Bruun, Kristian Bartnes, Lill‐Tove Busund, Anthony J. Chalmers, Roy M. Bremnes, Iñigo Martínez-Zubiaurre
Հրապարակվել է 2013Artigo -
17
Cancer Associated Fibroblasts in Stage I-IIIA NSCLC: Prognostic Impact and Their Correlations with Tumor Molecular Markers Thomas K. Kilvaer, Mehrdad Rakaee, Turid Hellevik, Samer Al‐Saad, Erna‐Elise Paulsen, Roy M. Bremnes, Lill‐Tove Busund, Tom Dønnem, Iñigo Martínez
Հրապարակվել է 2015Artigo -
18
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer Mehrdad Rakaee, Lill‐Tove Busund, Erna‐Elise Paulsen, Elin Richardsen, Samer Al‐Saad, Sigve Andersen, Tom Dønnem, Roy M. Bremnes, Thomas K. Kilvaer
Հրապարակվել է 2016Artigo -
19
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases Erna‐Elise Paulsen, Thomas K. Kilvaer, Mehrdad Rakaee, Elin Richardsen, Sigurd M. Hald, Sigve Andersen, Lill‐Tove Busund, Roy M. Bremnes, Tom Dønnem
Հրապարակվել է 2017Artigo -
20
High Progesterone Receptor Expression in Prostate Cancer Is Associated with Clinical Failure Thea Grindstad, Sigve Andersen, Samer Al‐Saad, Tom Dønnem, Yury Kiselev, Christian Melbø‐Jørgensen, Kaja Skjefstad, Lill‐Tove Busund, Roy M. Bremnes, Elin Richardsen
Հրապարակվել է 2015Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Medicine
Internal medicine
Cancer
Oncology
Pathology
Cancer research
Immunohistochemistry
Biology
Tissue microarray
Lung cancer
Stromal cell
Immunology
Immune system
Gene
Multivariate analysis
Univariate analysis
CD8
Paleontology
Prostate cancer
Stage (stratigraphy)
Angiogenesis
Biochemistry
Lymph node
Prostate
microRNA
Confidence interval
Genetics
Hazard ratio
Metastasis
Prostatectomy